Lactiga

About

Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients

Princeton,New Jersey,United States
1 - 10

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $75K
Industries: Biotechnology,Pharmaceutical
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: Lactiga, Inc.
Also Known As: Lactiga Therapeutics.

Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk to battle even the world’s most dangerous pathogens.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$3.08M $5K

Lactiga has raised a total of $3.08M $5K in funding over 2 rounds. Their latest funding was raised on Sep 21, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 21, 2022	Grant	$350K	2	—	—	Detail
Sep 21, 2022	Pre-seed	$1.25M	1	1517 Fund	—	Detail
May 31, 2021	Grant	$5K	1	—	—	Detail
Dec 1, 2020	Pre-seed	$1.40M	4	Checkmate Capital	—	Detail
Sep 29, 2020	Grant	$10K	1	LaunchYU	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

8

Lactiga is funded by 8 investors. 1517 Fund and Checkmate Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
1517 Fund	Yes	Pre-seed
Checkmate Capital	Yes	Pre-seed
LaunchYU	Yes	Grant
National Institutes of Health	Yes	Grant
Innovation Factory (Canada)	—	Grant
NJEDA	—	Grant
Unnamed Investor	—	Grant
Jude Gomila	—	Pre-seed